Personalized Computerized Inhibitory Control Training for OCD

Obsessive-Compulsive Disorder Clinical Trial

Official title:

Personalized Computerized Inhibitory Control Training for OCD

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02378896
• Other study ID #: #7059
• Status: Completed
• Phase: N/A
• First received: February 27, 2015
• Last updated: January 25, 2018
• Start date: February 2015
• Est. completion date: January 2018

Study information

• Verified date: January 2018
• Source: New York State Psychiatric Institute
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study will evaluate the effects of a computerized training program coupled with cognitive behavioral therapy (CBT) for OCD.

Description:

This study will evaluate the effectiveness of a computerized training program (called Personalized Computerized Inhibitory Training, or PCIT) coupled with cognitive behavioral therapies (CBT) consisting of Exposures and Response Prevention in treating obsessive compulsive disorder (OCD) in patients who previously underwent CBT, but still have residual symptoms.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 11
• Est. completion date: January 2018
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Principal diagnosis of OCD (assessed by SCID).

• Clinically significant OCD symptoms (Y-BOCS score of at least 16).

• Have a history of completing a trial of at least 1 EX/RP sessions.

• Have access to a computer or laptop.

Exclusion Criteria:

• Individuals with the following disorders will excluded: bipolar, psychosis, current major depressive disorder (assessed by SCID).

• Patients with head injury and loss of consciousness of more than five minutes or a neurological condition affecting the central nervous system.

• Patients taking a psychiatric medication will be asked to maintain a stable dose for 6 weeks prior to study entry.

• Vision or hearing loss (although individuals with vision corrected by glasses or contacts will not be excluded).

• Active suicidality warranting immediate clinical care.

Related Conditions & MeSH terms

• Obsessive-Compulsive Disorder

Intervention

Behavioral:
• Personalized Computer Program
Training with a personalized computerized inhibitory training program
• Cognitive Behavioral Therapy
Cognitive Behavioral Therapy (CBT), consisting of Exposure and Ritual Prevention Therapy

Locations

Country	Name	City	State
United States	New York State Psychiactic Institute	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
New York State Psychiatric Institute

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Obsessive-compulsive symptoms measured after 3 weeks of treatment	measured by Yale Brown Obsessive Compulsive Scale (YBOCS)	3 weeks